112 related articles for article (PubMed ID: 16427378)
1. Update on liver disease in hemophilia patients.
Kessler CM
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S13-7. PubMed ID: 16427378
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience.
Maor Y; Schapiro JM; Bashari D; Lurie Y; Safadi R; Segol O; Paritsky M; Rachlis Z; Avidan B; Bar-Meir S; Martinowitz U
Haemophilia; 2008 Mar; 14(2):336-42. PubMed ID: 18205802
[TBL] [Abstract][Full Text] [Related]
4. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Franchini M
Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
[TBL] [Abstract][Full Text] [Related]
5. Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes.
Kevans D; Farrell G; Hopkins S; Mahmud N; White B; Norris S; Bergin C
Haemophilia; 2007 Sep; 13(5):593-8. PubMed ID: 17880449
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatitis C in HIV infected and other immunocompromised individuals.
Seth AK
Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C in the hemophilia patient.
Fried MW
Am J Med; 1999 Dec; 107(6B):85S-89S. PubMed ID: 10653465
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
Pár A
Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis C in hemophiliacs.
Franchini M; Nicolini N; Capra F
Am J Hematol; 2006 Sep; 81(9):696-702. PubMed ID: 16838339
[TBL] [Abstract][Full Text] [Related]
11. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
[TBL] [Abstract][Full Text] [Related]
12. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV.
Dieterich DT; Purow JM; Rajapaksa R
Semin Liver Dis; 1999; 19 Suppl 1():87-94. PubMed ID: 10349696
[TBL] [Abstract][Full Text] [Related]
13. Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.
Moreno A; Moreno A; Pérez-Elías MJ; Quereda C; Fernández-Muñoz R; Antela A; Moreno L; Bárcena R; López-San Román A; Celma ML; García-Martos M; Moreno S
Hum Pathol; 2006 Oct; 37(10):1344-9. PubMed ID: 16949926
[TBL] [Abstract][Full Text] [Related]
14. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
[TBL] [Abstract][Full Text] [Related]
16. Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection.
Aghemo A; Rumi MG; Soffredini R; D'Ambrosio R; Ronchi G; Del Ninno E; Gallus S; Colombo M
Antivir Ther; 2006; 11(6):797-802. PubMed ID: 17310824
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
Reiberger T; Rasoul-Rockenschaub S; Rieger A; Ferenci P; Gangl A; Peck-Radosavljevic M
Eur J Clin Invest; 2008 Jun; 38(6):421-9. PubMed ID: 18489402
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
Tural C; Solà R; Rubio R; Santín M; Planas R; Quereda C; Berenguer J; Montes-Ramírez M; Clotet B;
J Viral Hepat; 2007 Oct; 14(10):704-13. PubMed ID: 17875005
[TBL] [Abstract][Full Text] [Related]
19. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
[TBL] [Abstract][Full Text] [Related]
20. Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients.
Payan C; Pivert A; Morand P; Fafi-Kremer S; Carrat F; Pol S; Cacoub P; Perronne C; Lunel F;
Gut; 2007 Aug; 56(8):1111-6. PubMed ID: 17363475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
